文献速递肺结节与肺癌

基于联盟数据的肺癌跨组学基因-吸烟交互作用研究

A trans-omics gene-smoking interaction study of lung cancer based on consortium data.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01

该研究整合ILCCO-OncoArray、TRICL、PLCO和UKB共27 737例病例与449 910例非病例的个体基因型数据与联盟级分子QTL汇总数据,开展首个肺癌跨组学基因-吸烟交互作用研究。研究识别出8个与吸烟显著交互的生物标志物,并构建分子修饰评分(MMS)以区分吸烟者的肺癌风险分层,跨组学整合分析提示NELFE基因参与吸烟相关致癌通路。

要点

  • 跨组学框架可系统发现基因-环境交互作用,识别出8个与吸烟显著交互的生物标志物。
  • 基于8个生物标志物构建的MMS可有效对吸烟者进行肺癌风险分层。
  • 跨组学整合分析提示NELFE基因参与吸烟相关致癌通路。

核心结论

  • 跨组学关联研究框架能够系统发现跨组学基因-环境交互作用。
  • MMS可有效刻画交互作用模式并促进风险分层。
  • 研究上线了免费在线平台LungCancer-xWAS-GxE。

研究设计与样本

  • 整合ILCCO-OncoArray、TRICL、PLCO和UKB的联盟级个体基因型数据,共27 737例病例与449 910例非病例。
  • 结合联盟级汇总分子QTL数据,涵盖DNA甲基化、基因表达、蛋白质和代谢物。
  • 采用两阶段分析策略识别与吸烟显著交互的生物标志物。

主要发现

  • 共识别出8个与吸烟显著交互的生物标志物。
  • 生物标志物包括烟碱型乙酰胆碱受体区域的CpG位点和基因RP11-326C3.14。
  • MMS整合上述生物标志物及其来自全部可用数据集荟萃分析的效果估计,可有效对吸烟者进行肺癌风险分层。
  • 跨组学整合分析揭示分子层间的功能关系,尤其提示NELFE基因参与吸烟相关致癌通路。

临床怎么用

  • 可利用MMS对吸烟人群进行肺癌风险分层。
  • 可通过在线平台LungCancer-xWAS-GxE(http://bigdata.njmu.edu.cn/LungCancer-xWAS-GxE/)使用相关资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Genetically predicted molecular traits provide a cost-effective approach for identifying biomarkers and uncovering underlying biological mechanisms. We extended this framework to investigate gene-smoking interactions in lung cancer susceptibility. OBJECTIVES: To identify trans-omics gene-smoking interactions affecting lung cancer risk and to assess how biomarkers modify effect of smoking. METHODS: We conducted the first trans-omics gene-smoking interaction study of lung cancer by integrating consortium-scale individual genotype data (27 737 cases vs 449 910 noncases) from the International Lung Cancer OncoArray Consortium (ILCCO-OncoArray), Transdisciplinary Research Into Cancer of the Lung (TRICL), Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), and the UK Biobank (UKB) with alliance-based summary-level molecular quantitative trait loci (xQTL) data, involving DNA methylation, gene expression, protein, and metabolite. Based on the identified biomarkers, we developed a molecular modifying score (MMS) to delineate gene-smoking interaction patterns and stratify smokers at high risk of lung cancer. MEASUREMENTS AND MAIN RESULTS: Eight biomarkers showing significant interactions with smoking were identified through a 2-phase analytic strategy, comprising CpG sites in the nicotinic acetylcholine receptor region and gene RP11-326C3.14. The MMS, constructed by integrating these biomarkers with their effect estimates derived from meta-analysis of all available datasets, effectively stratified lung cancer risk among smokers. Trans-omics integrative analysis revealed functional relationships across molecular layers, particularly implicating the NELFE gene in smoking-related carcinogenesis pathways. CONCLUSIONS: The trans-omics association study (xWAS) framework enables systematic discovery of trans-omics gene-environment interactions. The MMS effectively delineates the patterns of the interaction effects and facilitates risk stratification. Additionally, we launched a free online platform, LungCancer-xWAS-GxE (http://bigdata.njmu.edu.cn/LungCancer-xWAS-GxE/).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Xie N, Xu X, Wang Y, et al. A trans-omics gene-smoking interaction study of lung cancer based on consortium data. Am J Respir Crit Care Med. 2026. PMID: 41738161. doi:10.1093/ajrccm/aamaf097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。